CVS Noncontrolling Interest In Consolidated Entity from 2010 to 2025
| CVS Stock | USD 52.62 0.66 1.27% |
Noncontrolling Interest In Consolidated Entity | First Reported 2009-06-30 | Previous Quarter 198 M | Current Value 276 M | Quarterly Volatility 146.3 M |
Check CVS Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CVS Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 5.3 B, Interest Expense of 3.2 B or Selling General Administrative of 46.3 B, as well as many indicators such as Price To Sales Ratio of 0.62, Dividend Yield of 0.0244 or PTB Ratio of 2.61. CVS financial statements analysis is a perfect complement when working with CVS Health Valuation or Volatility modules.
CVS | Noncontrolling Interest In Consolidated Entity |
Latest CVS Health's Noncontrolling Interest In Consolidated Entity Growth Pattern
Below is the plot of the Noncontrolling Interest In Consolidated Entity of CVS Health Corp over the last few years. It is CVS Health's Noncontrolling Interest In Consolidated Entity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CVS Health's overall financial position and show how it may be relating to other accounts over time.
| Noncontrolling Interest In Consolidated Entity | 10 Years Trend |
|
Noncontrolling Interest In Consolidated Entity |
| Timeline |
CVS Noncontrolling Interest In Consolidated Entity Regression Statistics
| Arithmetic Mean | 160,578,125 | |
| Geometric Mean | 0.00 | |
| Coefficient Of Variation | 102.14 | |
| Mean Deviation | 158,078,125 | |
| Median | 300,000,000 | |
| Standard Deviation | 164,018,437 | |
| Sample Variance | 26902T | |
| Range | 362.2M | |
| R-Value | 0.89 | |
| Mean Square Error | 6164.8T | |
| R-Squared | 0.79 | |
| Slope | 30,545,221 | |
| Total Sum of Squares | 403530.7T |
CVS Noncontrolling Interest In Consolidated Entity History
About CVS Health Financial Statements
CVS Health shareholders use historical fundamental indicators, such as Noncontrolling Interest In Consolidated Entity, to determine how well the company is positioned to perform in the future. Although CVS Health investors may analyze each financial statement separately, they are all interrelated. The changes in CVS Health's assets and liabilities, for example, are also reflected in the revenues and expenses on on CVS Health's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Noncontrolling Interest In Consolidated Entity | 345 M | 362.2 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for CVS Stock Analysis
When running CVS Health's price analysis, check to measure CVS Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVS Health is operating at the current time. Most of CVS Health's value examination focuses on studying past and present price action to predict the probability of CVS Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVS Health's price. Additionally, you may evaluate how the addition of CVS Health to your portfolios can decrease your overall portfolio volatility.